|  |  | 

India Top Headlines

ICMR and NIV to study whether vaccines in India can neutralize the Delta Plus variant of the coronavirus | India News

img-responsive

NEW DELHI: Following the detection of the ‘Delta Plus’ variant in Covid patients in some parts of the country, the Indian Council for Medical Research (ICMR) and the National Institute of Virology (NIV) have decided to conduct a study to see if Las Existing vaccines in India may neutralize a new and more potent variant of the coronavirus.
According to the government, Delta Plus cases have been found in Maharashtra (Ratnagiri and Jalgaon) Kerala (Palakkad and Pathanamthitta) and in Madhya Pradesh (Bhopal and Shivpuri).
The study is likely to involve the Covaxin and Covishield vaccines. “The recently emerging Delta Plus variant has increased
transmissibility, increased capacity to bind to lung cells, and resistance to monoclonal antibody treatment. Looking at this scenario, the Delta Plus variant could be a concern, and high vigilance should be performed and containment of the affected area should reduce transmission, “said Dr. Pragya Yadav, head of the Maximum Containment Facility of the NIV.
When asked if existing vaccines can fight the Delta Plus variant, he said samples have been collected and a study is underway.
“Based on previous data on the Delta variant, neutralization was occurring with existing vaccines in India. Although the neutralization has decreased, it is sufficient to protect against the Delta variant. Delta Plus should also behave (similarly). We are working on it. in this direction We have isolated this variant and will soon carry out a study.
will come back with the study, “he said.
All Delta sublineages are treated as Variants of Interest (VOC) and the properties of AY.1 are still under investigation. Delta Plus too
known as variant ‘AY.1’ or B.1.617.2.1. The variable frequency of AY.1 is low in India. Cases with AY.1 have been reported mainly in nine countries in Europe, Asia and the Americas.



Original source

icmr-and-niv-to-study-whether-vaccines-in-india-can-neutralize-the-delta-plus-variant-of-the-coronavirus-india-news

ABOUT THE AUTHOR